Neuberger Berman Group LLC Sanofi Transaction History

Neuberger Berman Group LLC

$123 Billion
Q3 2024

A detailed history of Neuberger Berman Group LLC transactions in Sanofi stock. As of the latest transaction made, Neuberger Berman Group LLC holds 17,630 shares of SNY stock, worth $859,109. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,630

Previous 17,550 0.46%

Holding current value

$859,109

Previous $851,000 19.39%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$48.54 - $58.53 $3,883 - $4,682	80 Added 0.46%	17,630 $1.02 Million
Q2 2024 Nov 14, 2024	SELL	$45.39 - $50.36 $95,364 - $105,806	-2,101 Reduced 10.69%	17,550 $851,000
Q2 2024 Aug 13, 2024	SELL	$45.39 - $50.36 $95,364 - $105,806	-2,101 Reduced 10.69%	17,550 $851,000
Q1 2024 Nov 14, 2024	BUY	$45.75 - $52.48 $173,163 - $198,636	3,785 Added 23.86%	19,651 $955,000
Q1 2024 May 13, 2024	BUY	$45.75 - $52.48 $899,033 - $1.03 Million	19,651 New	19,651 $955,000
Q4 2023 Nov 14, 2024	SELL	$43.13 - $54.79 $72,630 - $92,266	-1,684 Reduced 9.6%	15,866 $789,000
Q4 2023 Feb 09, 2024	SELL	$43.13 - $54.79 $151,817 - $192,860	-3,520 Reduced 18.16%	15,866 $789,000
Q3 2023 Nov 14, 2023	BUY	$50.95 - $55.2 $3,311 - $3,588	65 Added 0.34%	19,386 $1.04 Million
Q2 2023 Aug 11, 2023	SELL	$50.45 - $57.18 $102,110 - $115,732	-2,024 Reduced 9.48%	19,321 $1.04 Million
Q1 2023 May 12, 2023	BUY	$45.86 - $54.45 $191,282 - $227,110	4,171 Added 24.29%	21,345 $1.16 Million
Q4 2022 Feb 13, 2023	BUY	$38.86 - $48.55 $7,344 - $9,175	189 Added 1.11%	17,174 $831,000
Q3 2022 Nov 15, 2022	SELL	$37.22 - $100.5 $88,174 - $238,084	-2,369 Reduced 12.24%	16,985 $645,000
Q2 2022 Aug 15, 2022	BUY	$48.99 - $57.46 $36,938 - $43,324	754 Added 4.05%	19,354 $968,000
Q1 2022 May 13, 2022	BUY	$48.48 - $53.65 $118,194 - $130,798	2,438 Added 15.08%	18,600 $814,000
Q4 2021 Feb 11, 2022	BUY	$47.07 - $52.35 $154,624 - $171,969	3,285 Added 25.51%	16,162 $699,000
Q3 2021 Nov 12, 2021	BUY	$47.89 - $53.12 $174,271 - $193,303	3,639 Added 39.39%	12,877 $611,000
Q2 2021 Aug 13, 2021	SELL	$49.36 - $54.25 $146,944 - $161,502	-2,977 Reduced 24.37%	9,238 $478,000
Q1 2021 May 13, 2021	BUY	$45.46 - $50.51 $23,593 - $26,214	519 Added 4.44%	12,215 $601,000
Q4 2020 Feb 10, 2021	SELL	$45.3 - $51.62 $775,581 - $883,786	-17,121 Reduced 59.41%	11,696 $569,000
Q3 2020 Nov 12, 2020	SELL	$49.47 - $53.77 $143,116 - $155,556	-2,893 Reduced 9.12%	28,817 $1.45 Million
Q2 2020 Aug 13, 2020	SELL	$42.91 - $52.5 $312,685 - $382,567	-7,287 Reduced 18.69%	31,710 $1.62 Million
Q1 2020 May 14, 2020	BUY	$38.02 - $51.66 $226,827 - $308,203	5,966 Added 18.06%	38,997 $1.7 Million
Q4 2019 Feb 12, 2020	BUY	$44.25 - $50.86 $131,776 - $151,461	2,978 Added 9.91%	33,031 $1.66 Million
Q3 2019 Nov 13, 2019	SELL	$40.34 - $46.64 $7,503 - $8,675	-186 Reduced 0.62%	30,053 $1.39 Million
Q2 2019 Aug 13, 2019	BUY	$40.43 - $44.3 $114,902 - $125,900	2,842 Added 10.37%	30,239 $1.31 Million
Q1 2019 May 13, 2019	SELL	$40.83 - $45.43 $81,823 - $91,041	-2,004 Reduced 6.82%	27,397 $1.21 Million
Q4 2018 Feb 12, 2019	SELL	$41.48 - $45.59 $759,913 - $835,208	-18,320 Reduced 38.39%	29,401 $1.28 Million
Q3 2018 Nov 13, 2018	SELL	$40.0 - $44.84 $746,480 - $836,804	-18,662 Reduced 28.11%	47,721 $2.13 Million
Q2 2018 Aug 13, 2018	SELL	$37.63 - $41.22 $181,338 - $198,639	-4,819 Reduced 6.77%	66,383 $2.66 Million
Q1 2018 May 08, 2018	SELL	$38.98 - $45.76 $227,604 - $267,192	-5,839 Reduced 7.58%	71,202 $2.85 Million
Q4 2017 Feb 14, 2018	SELL	$42.86 - $50.61 $712,461 - $841,290	-16,623 Reduced 17.75%	77,041 $3.31 Million
Q3 2017 Nov 15, 2017	BUY	$47.04 - $50.34 $4.41 Million - $4.72 Million	93,664	93,664 $4.66 Million

Others Institutions Holding SNY

# of Institutions

822

Shares Held

268M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $122B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Sanofi Transaction History